Photo of John A. Yarmuth
D United States House · District 3 · Kentucky

Rep. John A. Yarmuth

Compare
Total votes
958
all sessions
Attendance
86%
131 missed
Lower than 98% of chamber peers
With party
99%
of cast votes
Higher than 81% of chamber peers
Bipartisan score
0%
crosses aisle rarely
Lower than 82% of chamber peers
Sponsored
394
bills & resolutions
Near the chamber average
Committees
0
assignments
394 bills and resolutions

Sponsored bills

Total
394
Primary
19
Co-sponsor
375
This page
394
matching current filters
Co-sponsor HR 3183
In committee · United States House · Co-sponsor
Metastatic Breast Cancer Access to Care Act

Metastatic Breast Cancer Access to Care Act This bill expedites payment of Social Security Disability Insurance (SSDI) benefits and eligibility for Medicare coverage for those with metastatic breast cancer (i.e., breast cancer that has spread to other sites in the body). Specifically, the bill eliminates the 5-month waiting period for SSDI benefits and the subsequent 24-month waiting period for Medicare coverage for individuals with metastatic breast cancer. Under current law, individuals generally must wait five months after the onset of disability to begin receiving SSDI benefits and an additional 24 months to become eligible for Medicare.

In committee May 13, 2021 1 co-sponsor
Co-sponsor HR 3224
In committee · United States House · Co-sponsor
I am Vanessa Guillén Act of 2021

I am Vanessa Guillén Act of 2021 This bill addresses the policies and procedures of the Department of Defense (DOD) for cases or allegations of sex-related offenses.

In committee May 13, 2021 1 co-sponsor
Co-sponsor HR 3126
In committee · United States House · Co-sponsor
Healthy MOM Act

Healthy Maternity and Obstetric Medicine Act or the Healthy MOM Act This bill expands health insurance coverage availability for pregnant individuals. It requires health insurers, health insurance exchanges, and group health plans to offer a special enrollment period to pregnant individuals. The special enrollment period offered by an insurer or exchange must begin when the pregnancy is reported to the insurer or exchange. The special enrollment period offered by a group health plan must begin when the pregnancy is reported to the plan or is confirmed by a health care provider. The bill also makes pregnancy a qualifying life event for the purpose of enrolling in a federal employee health benefit plan. Additionally, a group health plan or health insurer that covers dependents must provide coverage for maternity care to all covered individuals. Any individual who is eligible for Medicaid and is, or becomes, pregnant maintains such eligibility for one year after the end of the pregnancy. The bill revises the range in which a state must establish a maximum level of family income for pregnant women and infants to be eligible for Medicaid. The upper limit of the range is eliminated and the lower limit is set to the level in place on January 1, 2014.

In committee May 12, 2021 1 co-sponsor
Co-sponsor HR 3089
In committee · United States House · Co-sponsor
Accelerating Kids’ Access to Care Act

Accelerating Kids' Access to Care Act This bill requires state Medicaid programs to establish a process through which qualifying out-of-state providers may enroll as participating providers without undergoing additional screening requirements. Among other things, a qualifying provider must (1) serve minors, or adults whose condition began as a minor; and (2) have previously been screened for Medicare participation or for participation in the Medicaid program of the state in which the provider is located.

In committee May 12, 2021 1 co-sponsor
Co-sponsor HR 3087
In committee · United States House · Co-sponsor
Breast Cancer Patient Equity Act

Breast Cancer Patient Equity Act This bill provides for Medicare coverage of custom fabricated breast prostheses following the surgical removal of the breast (i.e., a mastectomy), including replacements of such prostheses. Currently, Medicare covers surgically implanted breast prostheses, as well as some external breast prostheses (e.g., post-surgical bras).

In committee May 12, 2021 1 co-sponsor
Co-sponsor HR 3085
In committee · United States House · Co-sponsor
ENACT Act of 2021

Equity in Neuroscience and Alzheimer's Clinical Trials Act of 2021 or the ENACT Act of 2021 This bill sets out activities and requirements to increase the participation of underrepresented populations in research and clinical trials for Alzheimer's disease and related dementias. Specifically, the National Institute on Aging (NIA) must establish and provide technical assistance to Alzheimer's research centers located in areas with higher concentrations of minority groups. These centers must establish diagnostic and treatment clinics designed to serve minority, rural, and other underserved populations; operate clinical trials; and carry out public outreach to encourage members of minority populations to participate in clinical trials and research. Additionally, the NIA must disseminate information to members of minority populations about participating in clinical trials and take other actions to enhance diversity with respect to the Alzheimer's research that it conducts or supports. The bill also directs the NIA to increase diversity among Alzheimer's researchers by encouraging the participation of individuals who are from groups that are underrepresented in clinical, behavioral, and social sciences.

In committee May 12, 2021 1 co-sponsor
Co-sponsor HR 1755
In committee · United States House · Co-sponsor
Northern Rockies Ecosystem Protection Act

Northern Rockies Ecosystem Protection Act This bill designates specified National Forest System lands, National Park System lands, and public lands in Idaho, Montana, Oregon, Washington, and Wyoming as wilderness and as components or additions to existing components of the National Wilderness Preservation System. The Department of the Interior and the Department of Agriculture (USDA) must accept donations of leases or permits authorizing grazing on specified public or National Forest System lands. The bill also designates (1) specified federal lands as biological connecting corridors and as special corridor management areas; (2) segments of specified rivers and creeks in Idaho, Montana, and Wyoming as components of the National Wild and Scenic Rivers System; and (3) specified areas as wildland recovery areas. USDA shall develop a wildland recovery plan for each recovery area. A panel of independent scientists shall study roadless lands greater than 1,000 acres that are within the National Forest System in the Wild Rockies bioregion in Idaho, Montana, Oregon, Washington, or Wyoming and that are not designated as components of the National Wilderness Preservation System for their role in maintaining biological diversity in the Northern Rockies and as part of the overall forest reserve system. Any new road construction or reconstruction or timber harvest is prohibited in those lands after the evaluation without an act of Congress. Oil or gas leasing, mining, or other development which impairs the natural and roadless qualities of the land is also prohibited.

In committee May 12, 2021 1 co-sponsor
Showing 251 to 260 of 394 bills
Previous 1 … 25 26 27 … 40 Next